Other functions - cancer prevention agent development program: early phase clinical research

Ended Awarded Last action

Contract number
HHSN261201200035I
Awardee
Awarding agency
Task orders
15 $14,506,631 obligated

Award facts

Combined order value
  • $14,506,631 Current, with exercised options
  • $15,912,577 Potential, with all options
Last date to order 100% complete
IDV ceiling 17% used
$85,000,000.00
Award type
Multiple award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 8 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)

Award details come from SAM.gov/FPDS.

Task orders

Task order Ordering agency Obligated Awarded
Contract title - cancer prevention agent development program: early phase clinical research 75N91019F00130 National Cancer Institute (NIH) $2,031,556
A phase i single-arm, multicenter pilot study aimed at validating y-ohpdg as a biomarker and testing the effects of… HHSN26100013 National Cancer Institute (NIH) $789,841
Phase i trial of endoxifen GEL versus placebo GEL in women undergoing breast surgery HHSN26100014 National Cancer Institute (NIH) $416,271
Statin therapy to reduce disease progression from liver cirrhosis to cancer HHSN26100012 National Cancer Institute (NIH) $946,473
Phase IIB trial of neoadjuvant oral tamoxifen versus transdermal 4-hydroxytamoxifen in women with dcis of the breast HHSN26100011 National Cancer Institute (NIH) $1,159,347
Immunogenicity of nonavalent HPV vaccine administered prior to living donor renal transplantation in adult women: a… HHSN26100010 National Cancer Institute (NIH) $1,024,677
Evaluating intermittent dosing of aspirin for colorectal cancer prevention HHSN26100009 National Cancer Institute (NIH) $1,057,269
Core infrastructure support HHSN26100008 National Cancer Institute (NIH) $3,544,086
Statin therapy to reduce the risk of recurrent pancreatitis HHSN26100007 National Cancer Institute (NIH) $437,054
Contract HHSN261201200035I, 09/24/2012 - 09/23/2017CANCER prevention agent development program: early phase clinical… HHSN26100006 National Cancer Institute (NIH) $518,291
Phase i trial of berberine in subjects with ulcerative colitis HHSN26100005 National Cancer Institute (NIH) $96,000
A phase i trial of inhaled iloprost for the prevention of lung cancer in former smokers HHSN26100004 National Cancer Institute (NIH) $826,870
Intra-mammary distribution of transdermal telapristone versus oral telapristone: a randomized window trial in women… HHSN26100003 National Cancer Institute (NIH) $885,373
Core infrastructure support HHSN26100002 National Cancer Institute (NIH) $428,418
Other functions:cancer prevention agent development program: early phase clinical research- core infrastructure support HHSN26100001 National Cancer Institute (NIH) $345,105
Show all 15

Transactions

Action Obligated Date
Other Administrative Action P00007 · Otother functions - cancer prevention agent development program early phase clinical research $0
Other Administrative Action P00006 $0
Exercise an Option 5 $0
Exercise an Option 4 $0
Supplemental Agreement for work within scope 3 $0
Other Administrative Action 2 $0
Change Order 1 $0
Original award $0

Quick answers

Who was awarded contract HHSN261201200035I?

HHSN261201200035I was awarded to Northwestern University by National Cancer Institute (National Institutes of Health) on September 24, 2012.

How much is contract HHSN261201200035I worth?

Orders under HHSN261201200035I have obligated $14,506,631. Their combined potential value, with all options, is $15,912,577. HHSN261201200035I's own ceiling is $85,000,000.

How many orders have been placed under contract HHSN261201200035I?

15 orders have been placed under HHSN261201200035I, the latest on September 23, 2019.

Who can order from contract HHSN261201200035I?

HHSN261201200035I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract HHSN261201200035I part of a contract vehicle?

Yes. HHSN261201200035I is part of Cancer Prevention Agent Development Program 2012-2017.

Was contract HHSN261201200035I competed?

The extent of competition for HHSN261201200035I was full and open competition. The government received 8 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login